TGFB1 and acute myeloid leukemia: TGF-β1 were found to be significantly elevated in TDEs isolated from acute myeloid leukemia (AML) patients plasma, which can inhibit activation and functions of NK cells to downregulate cytotoxicity mediated by NK cells (Hong et al., 2014).